Birm and Prostate Cancer: University of Miami Medical School

by | May 15, 2003 | Archives

I have just learned that a scientific study at University of Miami Medical School has demonstrated that BIRM is a potent orally active anti-neoplastic agent, which primarily affects caspase-mediated apoptosis and inhibits metastasis by inhibition of hyaluronidase, an ECM-degrading enzyme implicated in tumor angiogenesis and metastasis.

You can read the whole thing at

For more on BIRM and how to gain the most important asset of all. Go to